Výsledky vyhledávání - "O F, Hidalgo"

Quimioterapia intra-arterial hepática en las metástasis del carcinoma colorrectal

Autor: O. F. Hidalgo, A. C. Gil, W. Campbell, V. Hidalgo, M. J. Santos, I. Henríquez, S. Martín, M. Sureda, L. M. Antón

Publikováno v: Revista de Medicina de la Universidad de Navarra. :169-176

Las metástasis hepáticas constituyen la mayor causa de mortalidad del carcinoma colorrectal. El éxito de diversos tratamientos ensayados hasta ahora ha sido sólo parcial. La administración de medicamentos citotóxicos en la arteria hepática per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bc63c63a0a92dc8fed248fa07437ddd2
https://doi.org/10.15581/021.6971

Zobrazit plný text záznamu

Intra-arterial Hepatic Treatment with Carboplatin (CBDCA) and 5-Fluorouracil (5-FU) in Metastases from Colorectal Carcinoma

Autor: Oscar Abuchaibe, O. F. Hidalgo, Fernando Pardo, E. Tangco, J. M. Vieitez, Joseba Rebollo, I. Bilbao

Publikováno v: American Journal of Clinical Oncology. 16:30-33

Thirty-one patients with hepatic metastases from colorectal carcinoma were treated with carboplatin (CBDCA), 55 mg/m2, given in a 4-hour intra-arterial infusion daily for 5 days, and 5-fluorouracil, 900 mg/m2, given in a 20-hour intra-arterial infusi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c5565b0dc5cc559c6572a9998324d9
https://doi.org/10.1097/00000421-199302000-00008

Zobrazit plný text záznamu

Urokinase combination chemotherapy in small cell lung cancer. A phase II study

Autor: J. Rebollo, D. Ortiz de Urbina, Felipe A. Calvo, Fabio A. González, S. Martin Algarra, O. F. Hidalgo, Antonio Brugarolas

Publikováno v: Cancer. 70:2624-2630

BACKGROUND AND METHODS Fifty-one patients with small cell lung cancer (SCLC) were treated with alternating urokinase (UK)-cyclophosphamide-doxorubicin (Adriamycin, Adria Laboratories, Columbus, OH)-vincristine and cisplatin-etoposide-vincristine. UK

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::caf6b04cb496a9892468e51fd5d1134e
https://doi.org/10.1002/1097-0142(19921201)70:11<2624::aid-cncr2820701110>3.0.co

Zobrazit plný text záznamu

Carboplatin (CBDCA), 5-fluorouracil (5-FU) and mitoxantrone (DHAD): An effective and well tolerated regimen for metastatic breast cancer

Autor: O. F. Hidalgo, F. G. Gonzalez, E. Tangco, P. Herranz, J. Rebollo, J. M. Vieitez

Publikováno v: Annals of Oncology. 3:545-548

Fifty-five women with metastatic breast cancer were treated with carboplatin (CBDCA), 55 mg/m2 i.v. bolus, daily for 3 days, 5-fluorouracil (5-FU) 900 mg/m2, (max. dose 1,500 mg/day in 24-h infusion (Travenol system) daily for 3 days, and mitoxantron

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d549be55f538f42ed06adf26eb8a19
https://doi.org/10.1093/oxfordjournals.annonc.a058257

Zobrazit plný text záznamu

Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon

Autor: O F, Hidalgo, J M, Aramendía, G, Alonso, J G, Foncillas, A, Brugarolas

Publikováno v: Revista de medicina de la Universidad de Navarra. 40(3)

The results of two sequential trials, the first one with high dose interleukin 2 (IL2) by continuous intravenous infusion and the second one with subcutaneous IL2 and alpha-interferon (alpha IFN), performed in consecutive patients with metastatic mel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3fe314029ee2e03acc4ac46aa6021a4e
https://pubmed.ncbi.nlm.nih.gov/9499820

Zobrazit plný text záznamu

Urokinase combination chemotherapy in small cell lung cancer. A phase II study

Autor: F A, Calvo, O F, Hidalgo, F, Gonzalez, J, Rebollo, S, Martin Algarra, D, Ortiz de Urbina, A, Brugarolas

Publikováno v: Cancer. 70(11)

Fifty-one patients with small cell lung cancer (SCLC) were treated with alternating urokinase (UK)-cyclophosphamide-doxorubicin (Adriamycin, Adria Laboratories, Columbus, OH)-vincristine and cisplatin-etoposide-vincristine. UK was given as a loading

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::407ca763ecd1a07147e34536ab3010c8
https://pubmed.ncbi.nlm.nih.gov/1330286

Zobrazit plný text záznamu

Phase I trial of intermittent high-dose dacarbazine

Autor: J M, Buesa, M, Gracia, M, Valle, E, Estrada, O F, Hidalgo, A J, Lacave

Publikováno v: Cancer treatment reports. 68(3)

A phase I study was conducted with dacarbazine (DTIC) protected from light and administered iv as a single dose every 3 weeks. Eighteen patients received 47 courses of DTIC, with doses ranging from 850 to 1980 mg/m2. Hypotension was the dose-limiting

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6002afe6887146b74f835bbc782ff643
https://pubmed.ncbi.nlm.nih.gov/6704980

Zobrazit plný text záznamu

[Intra-arterial chemotherapy, using the hepatic artery, in metastases of colorectal carcinoma]

Autor: O F, Hidalgo, A C, Gil, W, Campbell, V, Hidalgo, M, Santos, I, Henríquez, S, Martín, M, Sureda, L M, Antón

Publikováno v: Revista de medicina de la Universidad de Navarra. 31(3)

Hepatic metastasis is the major cause of death in advanced cancer of the colon and rectum. Various modes of therapy have been attempted with only partial success. Infusion of cytotoxic agents into the hepatic artery has allowed a higher concentration

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7ba73a0a26e83c622aa2f1f61a9999d9
https://pubmed.ncbi.nlm.nih.gov/3333892

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání